Pharma payments to medical oncologists under the microscope

Almost a third of Australian medical oncologists and haematologists receive payments from the pharmaceutical industry, a rate three times higher than the average for specialist physicians, new research shows. The authors of the study say the findings are a reflection of the influence of industry in funding development of expensive novel cancer therapies rather than ...